Anusha Gandi

Employment

• Vignan Institute of Pharmaceutical Technology Assistant Professor

Education

• School of Pharmaceutical Science M.Pharmacy (Ph.D)
  2014 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Novel RP-HPLC–PDA method for comprehensive stability indicating and impurity profiling for concurrent estimation of abiraterone and Niraparib in bulk and tablet formulation
  Future Journal of Pharmaceutical Sciences 2026 DOI: 10.1186/s43094-026-01015-5
  +Save
• Quality by design-driven RP-HPLC stability indicating method for concurrent estimation of enmetazobactam and cefepime in bulk and dosage form: a greenness and blueness approach
  Journal of the Iranian Chemical Society 2026 DOI: 10.1007/s13738-026-03409-x
  +Save
• QbD Guided Central Composite Design Optimized RP-HPLC Method for Teneligliptin Assay in Dosage Forms
  Current Trends in Biotechnology and Pharmacy 2026 DOI: 10.5530/ctbp.2026.2s.4
  +Save
• Quantification of Tezepelumab in rat plasma by Bio-analytical Stability Indicating Method Development and Validation using LCMS and its Implementation to Pharmacokinetics
  Research Journal of Pharmacy and Technology 2026 DOI: 10.52711/0974-360X.2026.00007
  +Save
• Central composite design based stability-indicating RP-HPLC method development and validation for the concurrent determination of Avutometinib and Defactinib in bulk and co-pack formulation with application to forced degradation studies
  Microchemical Journal 2026 DOI: 10.1016/j.microc.2026.119337
  +Save
• STRATEGIC QBD IMPLEMENTATION IN RPHPLC-PDA METHOD FOR SIMULTANEOUS QUANTIFICATION OF CYSTIC FIBROSIS DRUGS TEZACAFTOR AND IVACAFTOR
  Ankara Universitesi Eczacilik Fakultesi Dergisi 2025 DOI: 10.33483/jfpau.1544812
  +Save
• Quality by design-assisted stability-indicating RP-HPLC method development and validation of posaconazole and its related substances in active pharmaceutical ingredient
  Accreditation and Quality Assurance 2025 DOI: 10.1007/s00769-025-01676-4
  +Save
• A Novel RP-UPLC Technique for Quantification of Daunorubicin and Cytarabine Simultaneous in Combined Tablet Dosage Forms-Its Application in Monitoring Forced Degradation Studies
  Current Trends in Biotechnology and Pharmacy 2025 DOI: 10.5530/ctbp.2025.2s.10
  +Save
• A Comprehensive Novel Stability indicating Method Development and Validation for Simultaneous Assessment of Abiraterone and Niraparib in Bulk and Pharmaceutical Formulation by Ultra Performance Liquid Chromatography
  Jordan Journal of Pharmaceutical Sciences 2025 DOI: 10.35516/jjps.v18i3.3439
  +Save
• Stability-indicating RP-HPLC method using Box–Behnken design for simultaneous estimation of Abiraterone and Niraparib in bulk and combined dosage form with application to dissolution studies
  Accreditation and Quality Assurance 2025 DOI: 10.1007/s00769-025-01677-3
  +Save